5 completed. 5 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 5 | Completed 5 |
| Phase 2 | 2 | Completed 2 |
Follow Needles: new trials by email Literature Review of Needles trials Research Report on Needles
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| PK/PD Study of IN-001 Sublingual Spray in Healthy Adults Epinephrine Auto-Injector 0.3 mg/0.3 mL, Epinephrine 0.3 mg intramuscular manual injection via a syringe and needle, IN-001 9.06 mg Sublingual Spray - Food Allergy, Anaphylaxis | Phase 1 | Completed | Insignis Therapeutics, Inc. | 32 | 2025-10-24 | 2026-05-05 |
| A Study in Healthy Male Subjects to Investigate the Comparability of Pharmacokinetics of the Fixed-Dose Combination of Pertuzumab and Trastuzumab Administered Subcutaneously Using a Handheld Syringe or Using the On-Body Delivery System Fixed-Dose Combination of Pertuzumab and Trastuzumab SC (PH FDC SC), Handheld Syringe with Hypodermic Needle, On-Body Delivery System - Healthy Male Subjects | Phase 1 | Completed | Hoffmann-La Roche | 151 | 2022-05-30 | 2024-09-23 |
| Intradermal Rabies Immunization Using NanoJect: A Comparative Study NanoJect device (DebioJect™), Classical syringe (1mL Becton Dickinson (BD) Luer-Lock™) with a 25 Guage (G) needle (Terumo® Neolus), Classical syringe (1mL BD Luer-Lock™) with a 22G needle (Terumo® Neolus) - Intradermal (ID) Vaccination Device | Phase 1 | Completed | University of Lausanne Hospitals | 66 | 2013-08-01 | 2020-03-26 |
| Cryoablation of Venous Vascular Malformations Percutaneous Image-guided Cryoablation (FPRPR3508 IceRod® PLUS Needles) - Venous Vascular Malformation | Phase 1 / Phase 2 | Completed | University Hospital, Bordeaux | 14 | 2013-04-01 | 2026-05-14 |
| Study on the Effects on Blood Glucose Following Intradermal and Subcutaneous Dosing of Insulin in Diabetic Patients BD Research Catheter with 34G x 1.5 mm needle, Subcutaneous delivery of insulin using Disetronic Accu-Chek Rapid D infusion set - Diabetes | Phase 1 / Phase 2 | Completed | Becton, Dickinson and Company | 20 | 2010-04-01 | 2011-04-18 |
Anaphylaxis (1) · Diabetes Mellitus (1) · Food Hypersensitivity (1) · Insulin Resistance (1) · Pain (1) · Peanut Hypersensitivity (1)
Becton, Dickinson and Company (1) · Hoffmann-La Roche (1) · Insignis Therapeutics, Inc. (1) · University Hospital, Bordeaux (1) · University of Lausanne Hospitals (1)
Australia (1) · France (1) · Germany (1) · New Zealand (1) · United States (1)
Adelaide Doussau, MD (1) · Christoph Kapitza, MD (1) · Giuseppe Pantaleo (1) · Nancy Sweitzer (1)